Search for: "Schering Plough Corporation"
Results 81 - 100
of 100
Sorted by Relevance
|
Sort by Date
22 Jun 2011, 7:09 am
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
2 Oct 2010, 8:43 am
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
15 Feb 2012, 7:42 am
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:08 pm
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:07 pm
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
9 Sep 2011, 8:40 am
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:07 pm
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
14 Sep 2011, 12:08 pm
He also provides consulting services on corporate therapeutics and ethics guidelines. [read post]
21 Jun 2008, 10:01 pm
About 90% of the attendees were the chief legal officer of their companies or just a rung or two below, representing companies such as GE, Cisco, Tyco, Schering Plough, FMC, and other major companies you've heard of. [read post]
7 Jul 2010, 8:07 am
Schering-Plough Corp., 367 N.J. [read post]
23 Jul 2009, 3:15 am
We wouldn't base a motion solely on Actimmune, but with Pennsylvania Employees as the lead case, Actimmune is useful supporting precedent.Another candidate for best supporting actor in this area is In re Schering-Plough Corp. [read post]
12 Oct 2007, 7:03 am
Schering-Plough Corp., 2006 WL 2546494, at *2 (E.D. [read post]
16 Aug 2009, 11:23 am
., corporate buyers seeking to further their strategic objectives). [read post]
30 May 2011, 4:55 am
Egg World, LLC (Seattle Trademark Lawyer) Parties choose ACR, TTAB finds SOLARIN not confusingly similar to SOLARCAINE for sun/tanning products: Schering-Plough HealthCare Products, Inc. v. [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central… [read post]
3 Apr 2009, 7:23 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
12 May 2015, 3:26 pm
., Inc. 902619386 UBS Yield Optimization Notes with Contingent Protection linked to General Electric Company 902619394 UBS Yield Optimization Notes with Contingent Protection linked to Exxon Mobil Corp. 902619493 UBS Yield Optimization Notes with Contingent Protection linked to Texas Instruments Inc 902619519 UBS Yield Optimization Notes with Contingent Protection linked to Amgen Inc. 902619527 UBS Yield Optimization Notes with Contingent Protection linked to Goldcorp Inc. 902619535 UBS Yield… [read post]
23 Feb 2010, 6:16 am
Editor’s Note: John Olson is a founding partner of Gibson, Dunn & Crutcher’s Washington, D.C. office and a visiting professor at the Georgetown Law Center. [read post]
